Cape Verde vs Georgia: HIV-positive TB patients on ART (antiretroviral therapy)
Cape Verde
100.0%
in 2024
Georgia
100.0%
in 2024
Cape Verde rank
1st
Georgia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cape Verde
- Georgia
How they compare
Cape Verde currently reports 100.0% against 100.0% in Georgia, a difference of 0.0%.
The two have swapped places 4 times across 14 shared years of data; in 2005 it was Georgia ahead.
Cape Verde ranks 1st and Georgia ranks 1st of 144 countries.
Across the 3 decades both report, Cape Verde averaged higher in 1 and Georgia in 1.
Head to head by decade
| Decade | Cape Verde | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 93.6% | 93.1% | 0.5% | Cape Verde |
| 2020s | 90.4% | 96.6% | 6.2% | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cape Verde or Georgia?
- Cape Verde, at 100.0% against 100.0% in Georgia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cape Verde and Georgia?
- 0.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Georgia?
- 14 years are reported by both, from 2005 to 2024.
- How do Cape Verde and Georgia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cape Verde ranks 1st and Georgia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.